Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

6.065 -0.075 (-1.22%)
Streaming Delayed Price Updated: 11:23 AM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
Earnings Outlook For Vir Biotechnology ↗
Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vir... 
Via Benzinga
News headline image
Why HC Wainwright Is Bullish On This Stock's Hepatitis-B Pipeline ↗
 
Via Benzinga
News headline image
5 Value Stocks In The Healthcare Sector ↗
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
4 Undervalued Biotech Stocks to Add to Your Buy List ↗
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns. 
Via InvestorPlace
News headline image
Highly Rated GlaxoSmithKline Eyes Breakout After Racking Up Series Of Wins ↗
The move comes after the FDA shut down its Vir-partnered Covid antibody, however. 
Via Investor's Business Daily
News headline image
Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here ↗
 
Via Benzinga
News headline image
April Fool ↗
Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas. 
Via Talk Markets
News headline image
51 Biggest Movers From Yesterday ↗
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 100 points on Wednesday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0... 
Via Benzinga
News headline image
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge ↗
U.S. stocks traded lower midway through trading following the release of GDP data. 
Via Benzinga
News headline image
35 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales... 
Via Benzinga
News headline image
Vir Soars As Its Addition To SmallCap 600 Helps Wipe Out Recent Covid Volatility ↗
Vir Biotechnology remains under pressure despite its looming addition to a new index. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million. 
Via Benzinga
News headline image
24 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 77.9% to $6.85 in pre-market trading. Adagio Therapeutics said ADG20 (adintrevimab) is the first monoclonal antibody to meet... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Rise and shine, investor! It's time to go over the biggest pre-market stock movers in our breakdown for Wednesday morning! 
Via InvestorPlace
News headline image
Omicron BA.2 Variant Represents More Than 50% COVID-19 Cases, Says CDC Estimates: WSJ ↗
According to the Centers for Disease Control and Prevention estimates, the omicron BA.2 variant represents approximately 55% of new COVID-19 cases in the U.S., as signs suggest infections are edging... 
Via Benzinga
News headline image
Monday Markets News ↗
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved. 
Via Talk Markets
News headline image
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant ↗
 
Via Benzinga
News headline image
Drug makers, Scientists Working For Long COVID Treatments: Reuters ↗
Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID,  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
News headline image
64 Biggest Movers From Friday ↗
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed... 
Via Benzinga
News headline image
Up On Bad News ↗
Despite the plane crash in China, Boeing's stock is up today. 
Via Talk Markets
News headline image
World Markets News For Friday ↗
Buoyant global markets are closing the week and one good performer, Vir Biotech, today gained an impressive 6.09%. 
Via Talk Markets
News headline image
GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows ↗
According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE: GSK... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 524 stocks hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Taiwan... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
News headline image
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach ↗
Photo credit: Marcelo Leal and Kate Hliznitsova on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday morning, 66 companies achieved new lows for the year. Noteable 52-Week Lows: Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.